All news

Onterris gains as EPA visits PFAS treatment site

Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash

Onterris shares rose 2.18 percent to USD 14.52 on the NYSE after the EPA Administrator visited to observe its PFAS treatment technology. The visit provided a positive operational storyline even as the company reported a 20.4 percent drop in Q2 2026 revenue and lowered its full-year revenue guidance. Its SORBIX RePURE PFAS treatment technology is deployed worldwide, tying current policy discussions to an existing product.

Read original source

ONT company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.